BSGM Stock Overview
A medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
BioSig Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.94 |
| 52 Week High | US$2.57 |
| 52 Week Low | US$0.20 |
| Beta | 0.024 |
| 1 Month Change | 234.36% |
| 3 Month Change | 121.40% |
| 1 Year Change | 55.20% |
| 3 Year Change | -84.10% |
| 5 Year Change | -98.27% |
| Change since IPO | -97.58% |
Recent News & Updates
Recent updates
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now
Dec 12
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
Dec 14BioSig in acquisition pact with San Antonio Hospital for cardiac signal system
Oct 07BioSig: No Changes To Hold Thesis Following Q2 Earnings
Sep 08Shareholder Returns
| BSGM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 41.6% | 0.09% | -0.3% |
| 1Y | 55.2% | 7.7% | 8.1% |
Return vs Industry: BSGM exceeded the US Medical Equipment industry which returned 7.7% over the past year.
Return vs Market: BSGM exceeded the US Market which returned 8.1% over the past year.
Price Volatility
| BSGM volatility | |
|---|---|
| BSGM Average Weekly Movement | 23.3% |
| Medical Equipment Industry Average Movement | 9.7% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: BSGM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BSGM's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 5 | Anthony Amato | www.biosig.com |
BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company’s product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy.
BioSig Technologies, Inc. Fundamentals Summary
| BSGM fundamental statistics | |
|---|---|
| Market cap | US$47.05m |
| Earnings (TTM) | -US$10.51m |
| Revenue (TTM) | US$40.00k |
1,176x
P/S Ratio-4.5x
P/E RatioIs BSGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSGM income statement (TTM) | |
|---|---|
| Revenue | US$40.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$40.00k |
| Other Expenses | US$10.55m |
| Earnings | -US$10.51m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.43 |
| Gross Margin | 100.00% |
| Net Profit Margin | -26,282.50% |
| Debt/Equity Ratio | 0% |
How did BSGM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 00:36 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioSig Technologies, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Scott Henry | Roth Capital Partners |